Susan Hasty, Publisher
Table of Contents . . . January 13th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Diabetes Week | Other Publications
Diabetic Nephropathy - Angiotensin II receptor blockers top choice for preventing nephropathy in type 2 diabetics
Diabetic Nephropathy - Kidney glomeruli damaged by smoking
Coronary Artery Bypass - Bypass surgery more dangerous for diabetic patients
Diabetes - Stem cell transplants prevent development in mice
Diabetic Nephropathy - Sarpogrelate reduces urinary albumin excretion in type 2 diabetic patients
Heart Disease - Diabetes alone does not increase infective endocarditis morbidity or mortality
Appointments - Former Medtronic MiniMed executive joins Insulet
Cardiovascular Disease - Metabolic disease in men associated with greater risk
Diabetes Complications - Self-transplanted bone marrow cells restore flow to ischemic limbs
Diabetes Surgery - Gastric bypass surgery may be a cure for type 2 diabetes
Diabetic Retinopathy - New detection technique described
Finance - Pelikan successfully completes $14.0 million round of Series C financing
Insulin Analog - Novo Nordisk submits new drug application in the U.S. for NN304
Insulin Pumps - New technology helps young diabetes patients cope
Lipoatrophic Diabetes - New mouse model partially solves genetic puzzle
Multipotent Adult Progenitor Cells - New agreement targets development of adult stem cell technology
Obesity Therapy - Orlistat promoted weight loss in overweight adults also following a diet
Pediatric Diabetes - Environmental effects on childhood diabetes to be studied
Stock Market - SpectRx, Inc., to trade on NASDAQ SmallCap market
Type 2 Diabetes - Black and Hispanic kids more likely to be insulin-resistant
Weight Loss - Lasting improvements in metabolic function follow weight loss of at least 5%
Women's Health Diabetes - Lispro comparable with regular insulin for use during pregnancy in type 1 diabetic women
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.